<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Transmedics Group Inc — News on 6ix</title>
    <link>https://6ix.com/company/transmedics-group-inc</link>
    <description>Latest news and press releases for Transmedics Group Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 21 Apr 2026 20:05:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/transmedics-group-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835cb2b78dffbe2df11d0ae.webp</url>
      <title>Transmedics Group Inc</title>
      <link>https://6ix.com/company/transmedics-group-inc</link>
    </image>
    <item>
      <title>TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-to-report-first-quarter-2026-financial-results-on-may-5-2026</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-to-report-first-quarter-2026-financial-results-on-may-5-2026</guid>
      <pubDate>Tue, 21 Apr 2026 20:05:00 GMT</pubDate>
      <description>TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the first quarter 2026 after market close on Tuesday, May 5, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.</description>
    </item>
    <item>
      <title>TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-provides-additional-information-on-the-impact-of-the-release-of-the-valuation-allowance-on-deferred-tax-assets-on-previously-reported-fourth-quarter-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-provides-additional-information-on-the-impact-of-the-release-of-the-valuation-allowance-on-deferred-tax-assets-on-previously-reported-fourth-quarter-financial-results</guid>
      <pubDate>Fri, 27 Feb 2026 05:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., Feb. 27, 2026 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-fourth-quarter-and-full-year-2025-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-fourth-quarter-and-full-year-2025-financial-results</guid>
      <pubDate>Tue, 24 Feb 2026 21:05:00 GMT</pubDate>
      <description>TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter and year ended December 31, 2025.</description>
    </item>
    <item>
      <title>TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-report-fourth-quarter-full-210500187</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-report-fourth-quarter-full-210500187</guid>
      <pubDate>Tue, 10 Feb 2026 21:05:00 GMT</pubDate>
      <description>TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 24, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.</description>
    </item>
    <item>
      <title>TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-receives-full-unconditional-fda-130000443</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-receives-full-unconditional-fda-130000443</guid>
      <pubDate>Mon, 09 Feb 2026 13:00:00 GMT</pubDate>
      <description>TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug Administration (FDA) has granted full approval of its Investigational Device Exemption (IDE) for the Next-Generation OCS ENHANCE Heart trial. This follows full FDA approval of the company&apos;s Next-Generation OCS DENOVO Lung IDE trial in January 2026 and conditional I</description>
    </item>
    <item>
      <title>BioMed Realty and TransMedics Announce 498,000-Square-Foot Lease at Assembly Innovation Park</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/biomed-realty-transmedics-announce-498-131500191</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/biomed-realty-transmedics-announce-498-131500191</guid>
      <pubDate>Mon, 12 Jan 2026 13:15:00 GMT</pubDate>
      <description>SAN DIEGO &amp; SOMERVILLE, Mass., January 12, 2026--BioMed Realty, the largest privately-owned operator of real estate for the life science and technology industries, and TransMedics Group, Inc. (&quot;TransMedics&quot;, ticker: TMDX), a publicly traded medical technology company transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced that TransMedics has entered into a full building, 498,000-square-foot lease at Assembly Innovation Park, a premier life sci</description>
    </item>
    <item>
      <title>TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-announces-global-headquarters-expansion-131000823</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-announces-global-headquarters-expansion-131000823</guid>
      <pubDate>Mon, 12 Jan 2026 13:10:00 GMT</pubDate>
      <description>TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a global leader in organ transplant technologies and services, today announced the signing of a long-term lease for its new global headquarters at Assembly Innovation Park in Somerville, as well as the acquisition of the adjacent land parcel to create an integrated TransMedics campus environment. This strategic expansion reflects the company&apos;s commitment to accelerating the next wave of transplant innovations, growth, and the transformation</description>
    </item>
    <item>
      <title>TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-participate-44th-annual-jp-morgan-healthcare-conference-2025-12-30</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-participate-44th-annual-jp-morgan-healthcare-conference-2025-12-30</guid>
      <pubDate>Tue, 30 Dec 2025 05:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., Dec. 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2025-12-24</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-2025-12-24</guid>
      <pubDate>Wed, 24 Dec 2025 05:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., Dec. 24, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-participate-piper-sandler-37th-annual-healthcare-conference-2025-11-18</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-participate-piper-sandler-37th-annual-healthcare-conference-2025-11-18</guid>
      <pubDate>Tue, 18 Nov 2025 05:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., Nov. 18, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics Reports Third Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-third-quarter-2025-financial-results-2025-10-29</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-third-quarter-2025-financial-results-2025-10-29</guid>
      <pubDate>Wed, 29 Oct 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., Oct. 29, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics to Report Third Quarter 2025 Financial Results on October 29, 2025</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-report-third-quarter-2025-financial-results-october-29-2025-2025-10-15</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-report-third-quarter-2025-financial-results-october-29-2025-2025-10-15</guid>
      <pubDate>Wed, 15 Oct 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., Oct. 15, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics and Mercedes-Benz Announce Strategic Collaboration to Launch First Dedicated Organ Transplantation Ground Transportation Network in Italy</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-and-mercedes-benz-announce-strategic-collaboration-launch-first-dedicated</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-and-mercedes-benz-announce-strategic-collaboration-launch-first-dedicated</guid>
      <pubDate>Mon, 22 Sep 2025 04:00:00 GMT</pubDate>
      <description>Modern, purpose-built Mercedez-Benz V-Class fleet to be deployed across four National OCS Program (&quot;NOP&quot;) hubs in Italy to support utilization of TransMedics&apos;</description>
    </item>
    <item>
      <title>TransMedics to Present at Upcoming September Investor Conferences</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-present-upcoming-september-investor-conferences-2025-08-25</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-present-upcoming-september-investor-conferences-2025-08-25</guid>
      <pubDate>Mon, 25 Aug 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., Aug. 25, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics Receives FDA IDE Approval to Initiate Next-Generation OCS Heart Trial</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-receives-fda-ide-approval-initiate-next-generation-ocs-heart-trial-2025</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-receives-fda-ide-approval-initiate-next-generation-ocs-heart-trial-2025</guid>
      <pubDate>Mon, 04 Aug 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., Aug. 4, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics Reports Second Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-second-quarter-2025-financial-results-2025-07-30</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-second-quarter-2025-financial-results-2025-07-30</guid>
      <pubDate>Wed, 30 Jul 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., July 30, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics to Present at the Canaccord Genuity 45th Annual Growth Conference</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-present-canaccord-genuity-45th-annual-growth-conference-2025-07-29</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-present-canaccord-genuity-45th-annual-growth-conference-2025-07-29</guid>
      <pubDate>Tue, 29 Jul 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., July 29, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-report-second-quarter-2025-financial-results-july-30-2025-2025-07-23</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-report-second-quarter-2025-financial-results-july-30-2025-2025-07-23</guid>
      <pubDate>Wed, 16 Jul 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., July 16, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics to Present at Upcoming June Investor Conferences</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-present-upcoming-june-investor-conferences-2025-05-20</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-present-upcoming-june-investor-conferences-2025-05-20</guid>
      <pubDate>Tue, 20 May 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., May 20, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
    <item>
      <title>TransMedics Reports First Quarter 2025 Financial Results</title>
      <link>https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-first-quarter-2025-financial-results-2025-05-08</link>
      <guid isPermaLink="true">https://6ix.com/company/transmedics-group-inc/news/transmedics-reports-first-quarter-2025-financial-results-2025-05-08</guid>
      <pubDate>Thu, 08 May 2025 04:00:00 GMT</pubDate>
      <description>ANDOVER, Mass., May 8, 2025 /PRNewswire/ -- TransMedics Group, Inc. (&quot;TransMedics&quot;) (Nasdaq: TMDX), a medical technology company that is transforming organ</description>
    </item>
  </channel>
</rss>